Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes

被引:83
作者
Sasaki, Rumi [1 ,2 ]
Narisawa-Saito, Mako [1 ]
Yugawa, Takashi [1 ]
Fujita, Masatoshi [1 ]
Tashiro, Hironori [2 ]
Katabuchi, Hidetaka [2 ]
Kiyono, Tohru [1 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Virol, Chuo Ku, Tokyo 1040045, Japan
[2] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Gynecol, Kumamoto 8608556, Japan
关键词
MOUSE MODEL; PROGNOSTIC-SIGNIFICANCE; MOLECULAR PATHOLOGY; PIK3CA GENE; IN-VITRO; C-MYC; CANCER; BCL-2; EXPRESSION; TUMORS;
D O I
10.1093/carcin/bgp007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian surface epithelium (OSE) is considered to give rise to epithelial ovarian carcinomas (EOCs). To elucidate early processes contributing to the development of EOCs from the OSE, two batches of primary human OSE cells were transduced with non-viral human genes (mutant Cdk4, cyclinD1 and hTERT) so as to efficiently establish normal diploid OSE cells without chromosomal instability. Then defined genetic alterations frequently observed in EOCs were transduced into the OSE cells. A combination of p53 inactivation and oncogenic Kras transduction did not confer tumor-forming ability in immunodeficient mice, though additional transduction of Akt or combined transduction of c-myc with bcl-2 did result in tumor formation. In the latter case, tumors demonstrated phenotypes reminiscent of human EOCs, including cytokeratin expression, a highly aggressive phenotype, metastatic behavior and formation of ascites. These results indicate that inactivation of p53 and activation of the Ras pathway play critical roles in ovarian carcinogenesis in co-operation with the Akt or c-myc pathways. This first in vitro model system faithfully recapitulating the development of EOCs using normal human OSE cells should greatly facilitate further studies of EOCs.
引用
收藏
页码:423 / 431
页数:9
相关论文
共 50 条
[1]   Ovarian surface epithelium: Biology, endocrinology, and pathology [J].
Auersperg, N ;
Wong, AST ;
Choi, KC ;
Kang, SK ;
Leung, PCK .
ENDOCRINE REVIEWS, 2001, 22 (02) :255-288
[2]  
Aunoble B, 2000, INT J ONCOL, V16, P567
[3]  
Beale PJ, 2000, BRIT J CANCER, V82, P436
[4]   Origins and molecular pathology of ovarian cancer [J].
Bell, DA .
MODERN PATHOLOGY, 2005, 18 :S19-S32
[5]  
BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO
[6]  
2-L
[7]   Mutation of the PIK3CA gene in ovarian and breast cancer [J].
Campbell, IG ;
Russell, SE ;
Choong, DYH ;
Montgomery, KG ;
Ciavarella, ML ;
Hooi, CSF ;
Cristiano, BE ;
Pearson, RB ;
Phillips, WA .
CANCER RESEARCH, 2004, 64 (21) :7678-7681
[8]   Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract [J].
Cheng, WJ ;
Liu, JS ;
Yoshida, H ;
Rosen, D ;
Naora, H .
NATURE MEDICINE, 2005, 11 (05) :531-537
[9]  
Connolly DC, 2003, CANCER RES, V63, P1389
[10]   Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer [J].
Crum, Christopher P. ;
Drapkin, Ronny ;
Kindelberger, David ;
Medeiros, Fabiola ;
Miron, Alexander ;
Lee, Yonghee .
CLINICAL MEDICINE & RESEARCH, 2007, 5 (01) :35-44